https://generatebiomedicines.com/news-releases/ 2026-07-14T18:52:02+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-inc-reports-first-quarter-2026-financial-results-and-provides-business-update/ 2026-07-13T20:39:04+00:00 https://generatebiomedicines.com/news-releases/series-c-financing-announcement/ 2026-07-13T20:50:29+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-appoints-dr-alexandra-snyder-as-executive-vice-president-research-development/ 2026-07-13T20:52:09+00:00 https://generatebiomedicines.com/news-releases/amgen-and-generate-biomedicines-announce-multi-target-multi-modality-research-collaboration-agreement/ 2026-07-13T21:03:05+00:00 https://generatebiomedicines.com/news-releases/flagship-pioneerings-scientists-invent-machine-learning-powered-platform-to-generate-novel-biomedicines/ 2026-07-13T21:05:11+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-expands-c-suite/ 2026-07-14T14:39:58+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-expands-board-of-directors/ 2026-07-14T14:39:59+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-fortifies-leadership-in-generative-ai/ 2026-07-14T14:41:33+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-announces-publication-of-its-chroma-model-in-nature/ 2026-07-14T14:41:36+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-and-roswell-park-comprehensive-cancer-center/ 2026-07-14T14:41:38+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-unveils-state-of-the-art-cryoem-laboratory-to-accelerate-generative-ai-drug-discovery-and-development/ 2026-07-14T14:41:43+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-and-md-anderson-enter-co-development-and-commercialization-agreement-to-accelerate-novel-protein-therapeutics-for-oncology-using-generative-ai/ 2026-07-14T14:43:18+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-names-beth-grous-chief-people-officer/ 2026-07-14T14:43:36+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/ 2026-07-14T14:44:58+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-demonstrates-a-novel-method-of-reducing-immunogenicity-through-protein-re-surfacing/ 2026-07-14T14:45:08+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-expands-board-of-directors-with-jane-mendillo-former-ceo-of-the-harvard-management-company/ 2026-07-14T14:45:11+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-expands-leadership-team-with-chief-digital-officer/ 2026-07-14T14:45:28+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-uses-ai-to-create-proteins-that-have-never-existed/ 2026-07-14T14:46:00+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-grows-leadership-team-with-head-of-vaccines-and-infectious-disease-research-and-senior-vice-president-of-technical-operations/ 2026-07-14T14:46:10+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-expands-leadership-team-with-the-addition-of-chief-medical-officer-alexandra-snyder-m-d/ 2026-07-14T14:46:11+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-bolsters-leadership-team-with-the-addition-of-jason-silvers-m-d-j-d-as-chief-financial-officer/ 2026-07-14T14:46:15+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-expands-leadership-team-with-addition-of-sean-martin-as-chief-legal-officer-and-general-counsel/ 2026-07-14T14:46:16+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-announces-first-external-equity-raise-of-370-million-to-advance-its-drug-generation-platform/ 2026-07-14T14:46:38+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-inc-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference/ 2026-07-14T18:50:40+00:00 https://generatebiomedicines.com/news-releases/generate-biomedicines-inc-announces-pricing-of-initial-public-offering/ 2026-07-14T18:50:50+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-welcomes-aarif-khakoo-md-mba-as-chief-scientific-officer/ 2026-07-14T18:50:57+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-to-initiate-global-phase-3-studies-of-gb-0895-a-long-acting-anti-tslp-antibody-for-severe-asthma-engineered-with-ai/ 2026-07-14T18:51:05+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-to-present-phase-1-results/ 2026-07-14T18:51:17+00:00 https://generatebiomedicines.com/news-releases/generate-welcomes-laurie-lee/ 2026-07-14T18:51:24+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-expands-board-of-directors-with-appointment-of-marsha-fanucci/ 2026-07-14T18:51:40+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-provides-update-on-its-platform-and-pipeline/ 2026-07-14T18:51:47+00:00 https://generatebiomedicines.com/news-releases/generatebiomedicines-announces-multi-target-collaboration-with-novartis/ 2026-07-14T18:52:02+00:00